Keppel Ltd stock jumps 3% after SGX filing as investors eye next catalyst
13 January 2026
1 min read

Keppel Ltd stock jumps 3% after SGX filing as investors eye next catalyst

Singapore, Jan 13, 2026, 14:58 SGT — Regular session

  • Keppel shares rose roughly 3% in afternoon trading, pushing their gains for the year higher among Singapore blue chips
  • A company filing confirmed that the voluntary liquidation of a dormant unit has been finalized
  • Attention now turns to February results, along with any news on asset sales and fee income

Keppel Ltd shares climbed 3.1% to SG$10.82 by 2:48 p.m. Singapore time, on roughly 3.1 million shares changing hands. The movement followed the company’s announcement that it completed the member’s voluntary liquidation of its dormant unit, Keppel Technology and Innovation Pte. Ltd., though it did not specify any financial impact. 1

In a major Singapore blue chip, a move this big tends to trigger momentum trades, even if the underlying news is sparse. It hits right as investors begin positioning for February earnings and guidance.

Singapore’s market kicked off 2026 on a strong note, helped by a positive backdrop. The Straits Times Index has climbed roughly 2.1% year-to-date. “January optimism or pessimism often reflects investor confidence,” said OCBC’s head of equity research Carmen Lee. 2

The liquidation disclosure is mostly corporate housekeeping, yet it ties into a broader trend traders have focused on: streamlining structures, cutting distractions, and shifting cash and talent toward fee-generating, recurring-income areas. This isn’t a quick fix, but it can support the stock’s value over time.

Keppel is shifting its image from a traditional conglomerate to a manager and operator of real assets, covering infrastructure, real estate, and connectivity. This blend tends to make its shares reactive to changes in risk appetite and investors’ expectations on where interest rates will land.

Still, the near-term outlook is mixed. CEO Loh Chin Hua flagged “market volatility” in 2026 in his New Year message. He also highlighted challenges from China’s real estate sector as Keppel moves to “substantially monetis[e]” its non-core assets and boost funds under management (client assets). 3

If February’s results show weaker fee income, slower asset sales, or a more cautious stance on capital returns, that stock bump could vanish quickly. A minor filing won’t shield you from a disappointing quarter.

Traders are also keeping an eye out for new Singapore Exchange disclosures on buybacks, disposals, or funding — the routine updates that often pack more punch than big headlines when a stock is already gaining momentum.

The next key event is earnings: Keppel will release its second-half and full-year 2025 results on Feb. 5 before the market opens, a notice revealed. This follows earnings reports from its listed REITs on Jan. 30, Feb. 3, and Feb. 4.

Stock Market Today

GOOG stock price: Alphabet’s $185 billion AI spend plan keeps Google shares on edge into Monday

7 February 2026
New York, Feb 7, 2026, 09:34 EST — Market closed. Alphabet’s non-voting Class C shares (GOOG) closed down 2.48% at $323.10 on Friday, extending a pullback after the Google parent flagged a sharp jump in spending tied to artificial intelligence. 1 With U.S. markets shut for the weekend, the near-term test is whether investors keep treating Big Tech’s AI build-out as a cost problem before it becomes a growth story. A Reuters review of the week’s trading showed fresh jitters around 2026 outlays across the sector, and SanJac Alpha chief investment officer Andrew Wells said the AI trade “got too
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Allegiant to buy Sun Country in $1.5B deal as budget airline stocks split
Previous Story

Allegiant to buy Sun Country in $1.5B deal as budget airline stocks split

Yangzijiang Shipbuilding stock pops nearly 2% as fresh money chases Singapore cyclicals
Next Story

Yangzijiang Shipbuilding stock pops nearly 2% as fresh money chases Singapore cyclicals

Go toTop